vs
Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.
CB Financial Services, Inc. is the larger business by last-quarter revenue ($13.8M vs $13.3M, roughly 1.0× OCULAR THERAPEUTIX, INC). On growth, CB Financial Services, Inc. posted the faster year-over-year revenue change (19.9% vs -22.4%). CB Financial Services, Inc. produced more free cash flow last quarter ($17.2M vs $-57.1M). Over the past eight quarters, CB Financial Services, Inc.'s revenue compounded faster (1.2% CAGR vs -5.3%).
CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.
Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.
CBFV vs OCUL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $13.3M |
| Net Profit | — | $-64.7M |
| Gross Margin | — | 88.0% |
| Operating Margin | 38.1% | -526.5% |
| Net Margin | — | -488.0% |
| Revenue YoY | 19.9% | -22.4% |
| Net Profit YoY | — | -33.6% |
| EPS (diluted) | $0.90 | $-0.27 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $13.3M | ||
| Q3 25 | $2.4M | $14.5M | ||
| Q2 25 | $13.5M | $13.5M | ||
| Q1 25 | $12.1M | $10.7M | ||
| Q4 24 | $13.2M | $17.1M | ||
| Q3 24 | $12.7M | $15.4M | ||
| Q2 24 | $12.2M | $16.4M | ||
| Q1 24 | $13.5M | $14.8M |
| Q4 25 | — | $-64.7M | ||
| Q3 25 | $-5.7M | $-69.4M | ||
| Q2 25 | $3.9M | $-67.8M | ||
| Q1 25 | $1.9M | $-64.1M | ||
| Q4 24 | — | $-48.4M | ||
| Q3 24 | $3.2M | $-36.5M | ||
| Q2 24 | $2.6M | $-43.8M | ||
| Q1 24 | $4.2M | $-64.8M |
| Q4 25 | — | 88.0% | ||
| Q3 25 | — | 87.8% | ||
| Q2 25 | — | 85.6% | ||
| Q1 25 | — | 88.2% | ||
| Q4 24 | — | 92.8% | ||
| Q3 24 | — | 89.9% | ||
| Q2 24 | — | 90.8% | ||
| Q1 24 | — | 91.0% |
| Q4 25 | 38.1% | -526.5% | ||
| Q3 25 | -289.8% | -472.3% | ||
| Q2 25 | 35.0% | -502.6% | ||
| Q1 25 | 19.3% | -597.5% | ||
| Q4 24 | 23.1% | -296.1% | ||
| Q3 24 | 31.2% | -298.2% | ||
| Q2 24 | 26.4% | -265.1% | ||
| Q1 24 | 37.9% | -214.0% |
| Q4 25 | — | -488.0% | ||
| Q3 25 | -235.2% | -477.3% | ||
| Q2 25 | 29.3% | -503.9% | ||
| Q1 25 | 15.8% | -598.7% | ||
| Q4 24 | — | -283.3% | ||
| Q3 24 | 25.3% | -236.6% | ||
| Q2 24 | 21.8% | -266.3% | ||
| Q1 24 | 31.1% | -438.9% |
| Q4 25 | $0.90 | $-0.27 | ||
| Q3 25 | $-1.07 | $-0.38 | ||
| Q2 25 | $0.74 | $-0.39 | ||
| Q1 25 | $0.35 | $-0.38 | ||
| Q4 24 | $0.45 | $-0.25 | ||
| Q3 24 | $0.60 | $-0.22 | ||
| Q2 24 | $0.51 | $-0.26 | ||
| Q1 24 | $0.82 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $31.7M | $737.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $157.5M | $654.3M |
| Total Assets | $1.5B | $808.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $31.7M | $737.1M | ||
| Q3 25 | $55.9M | $344.8M | ||
| Q2 25 | $64.5M | $391.1M | ||
| Q1 25 | $61.3M | $349.7M | ||
| Q4 24 | $49.6M | $392.1M | ||
| Q3 24 | $147.3M | $427.2M | ||
| Q2 24 | $142.6M | $459.7M | ||
| Q1 24 | $73.7M | $482.9M |
| Q4 25 | $157.5M | $654.3M | ||
| Q3 25 | $152.5M | $258.2M | ||
| Q2 25 | $148.4M | $305.9M | ||
| Q1 25 | $148.3M | $265.9M | ||
| Q4 24 | $147.4M | $315.3M | ||
| Q3 24 | $149.1M | $352.0M | ||
| Q2 24 | $142.9M | $377.7M | ||
| Q1 24 | $141.6M | $408.0M |
| Q4 25 | $1.5B | $808.1M | ||
| Q3 25 | $1.5B | $410.9M | ||
| Q2 25 | $1.5B | $451.3M | ||
| Q1 25 | $1.5B | $405.9M | ||
| Q4 24 | $1.5B | $457.9M | ||
| Q3 24 | $1.6B | $490.4M | ||
| Q2 24 | $1.6B | $517.1M | ||
| Q1 24 | $1.5B | $538.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $17.8M | $-54.2M |
| Free Cash FlowOCF − Capex | $17.2M | $-57.1M |
| FCF MarginFCF / Revenue | 124.1% | -430.9% |
| Capex IntensityCapex / Revenue | 4.7% | 21.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.5M | $-216.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $17.8M | $-54.2M | ||
| Q3 25 | $4.6M | $-50.7M | ||
| Q2 25 | $4.1M | $-55.2M | ||
| Q1 25 | $4.0M | $-44.7M | ||
| Q4 24 | $6.8M | $-39.4M | ||
| Q3 24 | $3.1M | $-36.6M | ||
| Q2 24 | $-1.2M | $-24.8M | ||
| Q1 24 | $3.3M | $-33.9M |
| Q4 25 | $17.2M | $-57.1M | ||
| Q3 25 | $4.5M | $-56.7M | ||
| Q2 25 | $3.9M | $-56.5M | ||
| Q1 25 | $3.9M | $-46.6M | ||
| Q4 24 | $3.4M | $-39.6M | ||
| Q3 24 | $2.2M | $-36.6M | ||
| Q2 24 | $-2.4M | $-25.5M | ||
| Q1 24 | $2.3M | $-34.1M |
| Q4 25 | 124.1% | -430.9% | ||
| Q3 25 | 186.5% | -390.0% | ||
| Q2 25 | 28.8% | -419.7% | ||
| Q1 25 | 32.5% | -435.6% | ||
| Q4 24 | 26.0% | -232.0% | ||
| Q3 24 | 17.4% | -237.6% | ||
| Q2 24 | -19.6% | -155.4% | ||
| Q1 24 | 17.0% | -231.1% |
| Q4 25 | 4.7% | 21.4% | ||
| Q3 25 | 4.3% | 41.2% | ||
| Q2 25 | 1.9% | 9.3% | ||
| Q1 25 | 0.8% | 18.1% | ||
| Q4 24 | 25.1% | 1.2% | ||
| Q3 24 | 6.7% | 0.6% | ||
| Q2 24 | 10.0% | 4.5% | ||
| Q1 24 | 7.2% | 1.7% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | -0.44× | — | ||
| Q1 24 | 0.78× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
